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ABSTRACT
We previously established that cells infected with herpes simplex virus 2 (HSV-2) are disrupted in their ability to form stress
granules (SGs) in response to oxidative stress and that this disruption is mediated by virion host shutoff protein (vhs), a virion-
associated endoribonuclease. Here, we test the requirement for vhs endoribonuclease activity in disruption of SG formation.We
analyzed the ability of HSV-2 vhs carrying the point mutation D215N, which ablates its endoribonuclease activity, to disrupt SG
formation in both transfected and infected cells. We present evidence that ablation of vhs endoribonuclease activity results in
defects in vhs-mediated disruption of SG formation. Furthermore, we demonstrate that preformed SGs can be disassembled by
HSV-2 infection in a manner that requires vhs endoribonuclease activity and that, befitting this ability to promote SG disassem-
bly, vhs is able to localize to SGs. Together these data indicate that endoribonuclease activity must be maintained in order for vhs
to disrupt SG formation.We propose a model whereby vhs-mediated destruction of SGmRNA promotes SG disassembly and
may also prevent SG assembly.
IMPORTANCE
Stress granules (SGs) are transient cytoplasmic structures that form when a cell is exposed to stress. SGs are emerging as poten-
tial barriers to viral infection, necessitating a more thorough understanding of their basic biology. We identified virion host
shutoff protein (vhs) as a herpes simplex virus 2 (HSV-2) protein capable of disrupting SG formation. As mRNA is a central com-
ponent of SGs and the best-characterized activity of vhs is as an endoribonuclease specific for mRNA in vivo, we investigated the
requirement for vhs endoribonuclease activity in disruption of SG formation. Our studies demonstrate that endoribonuclease
activity is required for vhs to disrupt SG formation and, more specifically, that SG disassembly can be driven by vhs endoribonu-
clease activity. Notably, during the course of these studies we discovered that there is an ordered departure of SG components
during their disassembly and, furthermore, that vhs itself has the capacity to localize to SGs.
Stress granules (SGs) are dynamic, non-membrane-bound cy-toplasmic compartments that contain translationally silent
mRNAs that remain associated with a cadre of translation initia-
tion proteins, poly(A) binding protein (PABP), and the small ri-
bosomal subunit in the form of messenger ribonucleoprotein
complexes (mRNPs) (1). SGs assemble rapidly in response to a
variety of stressful conditions and likewise can disassemble rapidly
when stress is alleviated. Natural stresses that eukaryotic cells en-
counter include starvation, elevated temperature (heat shock),
oxidation, and virus infection, all of which can be sensed by four
distinct eukaryotic initiation factor 2 (eIF2) kinases. Following the
sensing of stress, these kinases become activated and phosphory-
late the alpha subunit of eIF2 (eIF2), leading to a failure to ini-
tiate new rounds of translation (2). The ensuing stoppage in pro-
tein synthesis causes a sudden increase in mRNPs that are no
longer associated with translating ribosomes. An increase in cyto-
plasmic levels of free mRNPs has been proposed to be the seminal
event that initiates the assembly of SGs (1, 3). This notion is sup-
ported by observations that compounds that stop protein synthe-
sis by means that are mechanistically distinct from eIF2 phos-
phorylation, such as puromycin and pateamine A (PatA),
promote SG formation (4–6), while compounds that keep
mRNAs associated with 80S ribosomes, such as cycloheximide
and emetine, discourage SG formation (6). Further experimental
verification of the governing role of cytoplasmic levels of mRNPs
in SG assembly was recently provided by Pastré and colleagues,
who demonstrated that delivery of exogenous single-stranded nu-
cleic acid (RNA or DNA) to cells could promote SG formation (7),
and by the recent in vitro studies of Cech and colleagues, who
demonstrated that the formation of higher-order assemblages of
the RNA binding protein FUS (fused in sarcoma) could be seeded
by the addition of RNA (8). The steps leading from an increase in
cytoplasmic levels of free mRNPs to assembly of microscopically
visible cytoplasmic granules with a complex protein composition
are ill defined. The contribution of cellular proteins with both
RNA binding capacity and prion-like domains, such as Ras-GT-
Pase-activating SH3-domain-binding protein (G3BP) (9) and T
cell internal antigen 1 (TIA-1) (10), as well as many posttransla-
tional modifications, including dephosphorylation (9), methyl-
ation (11, 12), deacetylation (13), ubiquitination (13), O-GlcNac
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modification (14), and poly(ADP ribosyl)ation (PARylation)
(15–17), have all been implicated in the assembly of these cyto-
plasmic compartments. Weak intermolecular interactions facili-
tated by RNA binding proteins with prion-like domains in com-
bination with these various posttranslational modifications have
been proposed to allow mammalian SGs to exist in a liquid drop-
let-like state (18). Interactions between mRNPs and the cytoskel-
eton also contribute to SG assembly (19–23). The conventional
model of SG assembly along with the physical state in which SGs
exist has been challenged by recent work published by Parker and
colleagues. Their analysis of SGs using superresolution micros-
copy suggests that SGs have a stable core structure surrounded by
a more dynamic shell (24). Like SG assembly, SG disassembly can
also occur rapidly and is mechanistically ill defined. Reversal of
some of the posttranslational modifications implicated in SG as-
sembly can cause SG disassembly. For example, phosphorylation
of SG proteins G3BP and dual-specificity tyrosine-phosphoryla-
tion-regulated kinase 3 (DYRK3) leads to disassembly of SGs (9,
25), as does removal of poly(ADP ribose) (PAR) modifications by
PAR glycohydrolases (16).
We have established that cells infected with herpes simplex
virus 2 (HSV-2) have a disruption in their ability to form SGs in
response to treatment with arsenite, an inducer of oxidative stress
(26). The ability to form SGs in response to arsenite was restored
in cells infected with HSV-2 strains carrying a defective virion host
shutoff protein (vhs), implicating vhs as a viral protein involved in
disrupting arsenite-induced SG formation (27). Furthermore,
disruption of arsenite-induced SG formation can be observed in
cells transfected with a vhs expression plasmid, indicating that vhs
can mediate this disruption in the absence of other viral proteins
(27). vhs is a endoribonuclease (28, 29) encoded by the UL41 gene
(30, 31) and is a component of the tegument layer of alphaherpes-
virus virions (32, 33). Packaging of vhs into virions allows this
endoribonuclease to be delivered to the cytoplasm immediately
upon fusion of viral and cellular membranes and to commence the
degradation of cellular mRNAs in advance of de novo viral gene
expression. Cleavage of most mRNAs by vhs in vivo occurs within
the 5= untranslated region near the cap, and the resulting de-
capped mRNAs are then rapidly degraded by the cellular 5=¡3=
exonuclease XrnI (34, 35). Degradation of cellular mRNAs in
combination with disruptions in cellular mRNA biogenesis medi-
ated by the immediate early viral protein ICP27 led to consider-
able suppression of cellular protein synthesis (36, 37). Targeting of
vhs activity toward mRNAs in vivo may be facilitated by its ability
to bind the cellular translation initiation factors eIF4A, eIF4B, and
eIF4H (38–40). The ability of vhs to bind to translation initiation
factors may also be indicative of a direct role for vhs in translation.
Cap-independent translation via cis-acting elements and en-
hanced translation of viral late mRNAs have both been ascribed to
vhs (41–44). As vhs may interact with mRNA in two distinct man-
ners and has the ability to bind eIF4A, eIF4B, and eIF4H, all of
which are known SG components (45), predicting how vhs is able
to disrupt arsenite-induced SG formation is not straightforward.
The primary objective of this study was to examine the impact
of vhs endoribonuclease activity on SG formation. vhs shares se-
quence homology with the flap endonuclease 1 (FEN-1) family of
endonucleases (28), and the amino acids essential for the endori-
bonuclease activity of HSV-1 vhs have been thoroughly mapped
(40, 46). These mapping studies demonstrated that changing as-
partic acid 213 of HSV-1 vhs to asparagine (D213N) resulted in a
protein that lacked endoribonuclease activity yet retained the abil-
ity to bind both eIF4A and eIF4H. The analogous aspartic acid in
human FEN-1, aspartic acid 179, helps coordinate a metal ion-
binding pocket in the active site that is critical for catalytic activity
(47, 48). HSV-2 vhs shares 86% amino acid identity with HSV-1
vhs (49), and the analogous mutation in HSV-2 vhs (D215N) also
selectively ablates endoribonuclease activity (50). Utilizing a
D215N version of HSV-2 vhs, we present evidence that ablation of
vhs endoribonuclease activity results in defects in vhs-mediated
disruption of SG formation. We also demonstrate that preformed
SGs can be disassembled by HSV-2 infection in a manner that
requires the endoribonuclease activity of vhs and that, befitting
this ability to promote SG disassembly, vhs is able to localize to
SGs. We propose a model whereby destruction of mRNA by vhs
promotes SG disassembly and/or prevents SG assembly. This
model is in keeping with the seminal role proposed for RNA in
initiating SG formation and furthermore predicts that intact RNA
is crucial for maintaining the integrity of these cytoplasmic com-
partments.
MATERIALS AND METHODS
Cells and viruses. African green monkey kidney cells (Vero), cervical
carcinoma cells (HeLa), and A549 cells that stably produce enhanced
green fluorescent protein (EGFP)-G3BP1 (A549 SGG) (51) were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum (FBS) in a 5% CO2 environment. HSV-2
strain 186 virus (wild type [WT]) and UL41 virus (27) as well as the
D215N and repaired D215N (D215NRep) derivative viruses generated for
this study, were all propagated on Vero cells, and their titers were deter-
mined on Vero cells. To generate a high-titer stock of D215N virus to
facilitate high-multiplicity of infection (MOI) infections, confluent
150-mm dishes of Vero cells were inoculated at an MOI of 0.01 and then
incubated for 2 to 3 days at 34°C. Infected cells and medium were har-
vested together, and then infected cells were separated from medium by
centrifugation at 1,100 g for 5 min. The infected cell fraction was resus-
pended in SPGA buffer (218 mM sucrose, 3.8 mM KH2PO4, 7.2 mM
K2HPO4, 4.9 mM sodium glutamate, 1% [wt/vol] bovine serum albumin
[BSA], 10% FBS), and then cells were lysed by vortexing with sterile glass
beads (425 to 600m [Sigma, St. Louis, MO]). The infected cell lysate was
centrifuged at 2,000  g for 5 min, and the resulting supernatant was
aliquoted and stored at 80°C. Stocks of WT, D215NRep, and UL41
virus were prepared and stored in a similar manner. Unless otherwise
indicated, infection times refer to the length of time following a 1-h inoc-
ulation period.
Construction of recombinant HSV-2 strains. pYEbac373, the full-
length infectious HSV-2 186 bacterial artificial chromosome (BAC), was
constructed as described previously (52). A BAC carrying full-length vhs
with the point mutation D215N was constructed by the two-step Red-
mediated recombination procedure, using pYEbac373 in Escherichia coli
GS1783 (53).
Forward primer 5=-TCCAGGCCCAGTTTCGCCTTTTCC-3= and re-
verse primer 5=-GGTCAGCGTAGGCATGCTCTCCAG-3= were used to
amplify a product from pRF97 (described below) for the initial recombi-
nation step. Restriction fragment length polymorphism analysis following
EcoRI digestion was used to confirm the overall integrity of each recom-
binant BAC clone. Additionally, PCR fragments amplified from each re-
combinant BAC clone and from DNA isolated from the reconstituted
D215N virus were sequenced to verify that recombination had occurred at
the correct location within the viral genome, to verify that the D215N
mutation was present, and to verify that no additional mutations were
present within UL41. Virus was reconstituted from BAC DNA by trans-
fection of Vero cells as described previously (52). A similar strategy was
used to repair the D215N mutation (D215NRep) using a product ampli-
fied from pRF87 (27) for the initial recombination step.
Finnen et al.
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Single-step replication analysis. A total of 5  105 Vero cells were
seeded into 6-well dishes 1 day prior to infection. Vero cell monolayers
(approximately 1  106 cells per well) were infected at an MOI of 3. All
infections were performed in duplicate. After a 1-h inoculation period,
monolayers were treated for 2 min at 37°C with low-pH citrate buffer (40
mM Na citrate, 10 mM KCl, 135 mM NaCl [pH 3.0]) to inactivate extra-
cellular virions, washed once with medium, and then incubated at 37°C.
Infected monolayers were collected by scraping cells and medium to-
gether at 0, 4, 8, 12, 24, and 48 h postinoculation and stored at 80°C.
Samples were frozen at 80°C and thawed at 37°C twice and sonicated,
and the cellular debris was removed from the cell lysate by centrifugation.
The virus titers of the clarified lysates were determined in duplicate by
plaque assay on Vero cells.
Plasmids and transfections. The construction of an expression plas-
mid containing wild-type (WT) UL41, pRF78, was described previously
(27). A D215N mutation was introduced into the WT UL41 gene con-
tained within pRF78 by mutagenic PCR using forward primer 5=-GTAC
GTGCATACCACGAATACCGATCTCCTGC-3= and reverse primer 5=-
GCAGGAGATCGGTATTCGTGGTATGCACGTAC-3=. The resulting
plasmid, pRF96, was sequenced to ensure that no spurious mutations
were introduced into UL41 during construction. To construct a D215N
UL41 expression plasmid containing an I-SceI-flanked kanamycin cas-
sette with repeated UL41-derived sequence for facilitating two-step Red-
mediated recombination, an AscI fragment derived from pRF87, de-
scribed previously (27), was ligated to AscI-digested pRF96. The resulting
plasmid, pRF97, was screened for the ability to confer kanamycin resis-
tance and for correct orientation of the approximately 1,100-bp AscI frag-
ment by NotI digestion. An expression plasmid encoding an internally
gutted (IG) version of UL41 missing codons 24 through 474 was con-
structed by digesting pRF78 with ApaI then religating the digested plas-
mid. The resulting plasmid, pRF93, was then screened for loss of the
approximately 1,300-bp ApaI fragment. A myc tag was introduced on
to the amino terminus of D215N UL41 by annealing forward primer 5=-
CTAGCATGGAGCAGAAACTCATCTCTGAAGAGGATCTGGG-3= to
reverse primer 5=-AATTCCCAGATCCTCTTCAGAGATGAGTTTCTG
CTCCATG-3= to form a cassette containing myc tag coding sequence
flanked with NheI- and EcoRI-compatible cohesive ends. This cassette
was ligated into NheI/EcoRI-cut pRF96, and the resulting plasmid,
pRF99, was screened for loss of XhoI from the multiple-cloning site and
sequenced to ensure that the myc tag coding sequence was in frame with
D215N UL41. The mCherry red fluorescent protein expression plasmid,
pJR70, is a pEGFP-N1-based expression vector in which the enhanced
green fluorescent protein (EGFP) gene was replaced with the mCherry
gene (B. W. Banfield and J. A. Randall, unpublished data). Renilla lucif-
erase expression plasmid pRLSV40 was acquired from Promega (Pro-
mega, Madison, WI). Transfection of HeLa cells was carried out using
X-treme GENE HP DNA transfection reagent (Roche, Laval, QC, Can-
ada) according to the manufacturer’s protocols.
Induction of SGs. To induce SG formation, HeLa cells were treated
with 0.5 mM arsenite (Sigma, St. Louis, MO) for 30 min or 300 nM
desmethyl desamino pateamine A (DMDA PatA) (54) for 30 min at 37°C.
Immunological reagents. Goat polyclonal antiserum against human
TIA-1 (Santa Cruz Biotechnology, Santa Cruz, CA) was used for indirect
immunofluorescence microscopy at a dilution of 1:500. Mouse monoclo-
nal antibody against human G3BP (BD Biosciences, Mississauga, ON,
Canada) was used for indirect immunofluorescence microscopy at a di-
lution of 1:1,000. Mouse monoclonal antibody against HSV ICP27 (Viru-
sys, Taneytown, MD) was used for indirect immunofluorescence micros-
copy at a dilution of 1:1,000. Rat polyclonal antiserum against HSV-2 Us3
(55) was used for indirect immunofluorescence microscopy at a dilution
of 1:500. Mouse monoclonal antibody against the myc tag (Roche, Laval,
QC, Canada) was used for immunofluorescence microscopy at a dilution
of 1:200. Rabbit polyclonal antiserum against HSV vhs (56) was used for
Western blotting at a dilution of 1:3,000. Mouse monoclonal antibody
against HSV ICP5 (Virusys, Taneytown, MD) was used for Western blot-
ting at a dilution of 1:500. Alexa Fluor 488-conjugated donkey anti-goat
IgG, Alexa Fluor 488-conjugated donkey anti-mouse IgG, Alexa Fluor
488-conjugated donkey anti-rat IgG, Alexa Fluor 568-conjugated donkey
anti-mouse IgG, Alexa Fluor 647-conjugated donkey anti-mouse IgG, and
Alexa Fluor 647-conjugated chicken anti-rat IgG (Molecular Probes,
Eugene, OR) were all used for indirect immunofluorescence at a dilution
of 1:500. Horseradish peroxidase-conjugated goat anti-mouse IgG and
horseradish peroxidase-conjugated goat anti-rabbit IgG (Sigma, St. Louis,
MO) were used for Western blotting at a dilution of 1:10,000.
Indirect immunofluorescence microscopy. Cells for microscopic
analyses were grown on either glass coverslips or glass bottom dishes
(MatTek, Ashland, MA). Cells were fixed and stained as described previ-
ously (55). Stained cells were examined using either a Nikon Eclipse
TE200 inverted fluorescence microscope and Metamorph 7.1.2.0 software
or an Olympus FV1000 laser scanning confocal microscope and Fluoview
1.7.3.0 software. Images from the confocal microscope were captured us-
ing a 60 (1.42-numerical aperture [NA]) oil immersion objective. Com-
posites of representative images were prepared using Adobe Photoshop
software. Unpaired t tests of data yielded from microscopic analyses were
performed using GraphPad QuickCalcs.
Analysis of vhs packaging. For analysis of vhs packaging, virions were
purified as described previously (57). Confluent 150-mm dishes of Vero
cells were inoculated for 1 h at an MOI of 0.01. Two to 3 days later,
medium was collected. Collected medium was centrifuged three times in
succession at 1,100  g to pellet detached cells and cellular debris. The
clarified supernatant was layered over a cushion of 30% (wt/vol) sucrose
in phosphate-buffered saline (PBS) and centrifuged in a Beckman SW28
rotor at 23,000 rpm for 3 h. Pelleted virions were resuspended in 50 l of
1 SDS-PAGE loading buffer. Solubilized virions were then boiled for 5
min and stored at20°C prior to Western analyses. Western analyses of
virion preparations were performed as described previously (27).
RESULTS
vhs endonuclease activity is required todisrupt SG formation in
transfected cells. We developed a transfection-based assay to ex-
amine vhs endoribonuclease activity alongside vhs SG disruption
activity (Fig. 1A). HeLa cells were transfected with a mixture
containing equivalent amounts of vhs expression plasmid, an
mCherry expression plasmid for detection of transfected cells by
microscopy, and plasmid pRLSV40 for indirect monitoring of en-
doribonuclease activity by assaying Renilla luciferase activity. In
these assays, we compared cells transfected with the wild-type
(WT) vhs expression plasmid to cells transfected with the endori-
bonuclease-deficient vhs expression plasmid carrying a D215N
mutation in vhs and utilized an internally gutted (IG) vhs expres-
sion plasmid as a normalization control. IG vhs was constructed
by deleting the sequence contained between two internal in-frame
ApaI sites in the WT UL41 gene (Fig. 1B). This deletion removes
most of the coding capacity of UL41 (codons 24 through 474)
while maintaining the capacity for translation initiation and ter-
mination on mRNA transcripts generated from this construct.
The IG vhs expression plasmid performed similarly to the pCI-
neo parent vector in pilot luciferase assays (data not shown) and
IG vhs was used as a normalization control in subsequent lucifer-
ase assays. Cells transfected with WT vhs expression plasmid had
considerably reduced luciferase activity in comparison to cells
transfected with IG vhs (Fig. 1C). In contrast, levels of luciferase
activity were not significantly different between IG and D215N
transfections (P  0.2784), consistent with lack of endonuclease
activity in HSV-2 D215N vhs.
For our initial SG disruption assays, we treated transfected cells
with 0.5 mM arsenite to induce SG formation and then measured
the percentage of cells with visible SGs following staining for the
vhs Endoribonuclease Activity Drives SG Disruption
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SG marker TIA-1. Arsenite treatment promotes the phosphoryla-
tion of eIF2 in a heme-regulated inhibitor kinase-dependent
manner leading to translational arrest and the subsequent forma-
tion of SGs (58). Cells transfected with IG vhs performed compa-
rably to nontransfected (NT) cells following arsenite treatment
(Fig. 1D), indicating that transfection alone did not disrupt arsen-
ite-induced SG formation. SG disruption was readily detected in
cells transfected with WT vhs, and the fraction of cells lacking SGs
(approximately 65%) roughly corresponded to the transfection
efficiency in these experiments, predicted from averaged transfec-
tion efficiencies observed in IG transfections to be 58%. SG dis-
ruption was not observed in cells transfected with D215N vhs.
These data demonstrate that vhs endoribonuclease activity is re-
quired to disrupt arsenite-induced SG formation in transfected
cells.
SG formation can also be induced by means that are indepen-
dent of eIF2 phosphorylation. Pateamine A (PatA), a natural
product isolated from sea sponge, and its synthetic derivative des-
methyl desamino (DMDA) PatA are potent modulators of eIF4A
that also cause translational arrest and SG formation (4, 5, 54,
59–61). In our initial studies on the impact of HSV-2 infection on
SG formation, we found that infection interfered with the forma-
tion of arsenite-induced SGs but did not interfere with the forma-
tion of PatA-induced SGs (26). However, the SGs that formed in
HSV-2-infected cells following PatA treatment were largely de-
void of the SG marker TIA-1. To determine if these differential
effects on SG formation would also be seen in vhs-transfected
cells, we treated transfected cells with 300 nM DMDA PatA to
induce SGs and then measured the percentage of cells with visible
SGs. In order to detect differences in SG composition, this exper-
iment was performed in duplicate, samples were stained for either
TIA-1 or G3BP, and measurements of the percentage of cells with
visible SGs was performed using each marker independently (Fig.
1E). Disruption of DMDA PatA-induced SGs was observed in cells
transfected with WT vhs but not in cells transfected with D215N
vhs. Similar levels of SG disruption were seen in WT transfections
regardless of which SG marker was followed for quantitation, and
the fraction of cells lacking SGs (approximately 24% for TIA-1
and 19% for G3BP; P  0.1697) again roughly corresponded to
the transfection efficiency in these experiments, predicted from
averaged transfection efficiencies observed in IG transfections
(approximately 29% for TIA-1 and 28% for G3BP). Thus, when
overexpressed, vhs can disrupt SG formation caused by either
eIF2 phosphorylation-dependent or eIF2 phosphorylation-in-
dependent mechanisms of translational arrest, and vhs-mediated
disruption of SG formation requires endoribonuclease activity.
Disruption of SG formation by HSV-2 carrying an endonu-
clease-deficient vhs. To examine the requirement for vhs endori-
bonuclease activity in SG disruption in infected cells, we utilized
en passant mutagenesis to construct an HSV-2 strain 186 virus
FIG 1 Transfection-based assay to examine HSV-2 endonuclease activity and SG disruption. (A) HeLa cells transfected with equivalent amounts of HSV-2 vhs,
mCherry, and luciferase expression constructs were analyzed at 24 h posttransfection (hpt). (B) HSV-2 vhs expression constructs examined. The HSV-2 UL41
gene that encodes vhs is depicted by the blue line; vhs proteins are depicted by the gray bars. The red line indicates point mutation D215N, which was introduced
into full-length wild-type (WT) vhs to ablate its endoribonuclease activity. An internally gutted (IG) version of vhs was used as a normalization control. The
dashed line in IG vhs indicates an internal deletion of codons 24 to 474, generated by excising an in-frame ApaI fragment from UL41. (C) Results of luciferase
assays. Twenty microliters of lysates prepared from triplicate transfections or from nontransfected (NT) background controls was assayed using Promega’s
Stop&Glo reagent. Raw values were adjusted for background, and then the highest value obtained in the adjusted normalization control (IG) was set to 100, and
other values were scored relative to it. Data for the IG vhs were compiled from four independent experiments performed in triplicate; data for the WT and D215N
versions were compiled from three independent experiments performed in triplicate. Error bars indicate standard errors of the means. Unpaired t tests on
adjusted, normalized data were performed using GraphPad QuickCalcs. ****, P  0.0001; ns, difference not statistically significant. (D and E) SG disruption
results. Transfected cells were treated with 0.5 mM arsenite (D) or 300 nM DMDA PatA (E) for 30 min and then fixed. Samples in panel D were stained with goat
polyclonal antiserum specific for TIA-1 followed by staining with Alexa Fluor 488-conjugated donkey anti-goat IgG. Samples in panel E were stained with goat
polyclonal antiserum specific for TIA-1 followed by staining with Alexa Fluor 488-conjugated donkey anti-goat IgG or with mouse monoclonal antibody specific
for G3BP followed by staining with Alexa Fluor 488-conjugated donkey anti-mouse IgG. Samples were examined on an inverted epifluorescence microscope, and
the percentage of cells with SGs was scored in 10 fields per sample. Data in panel D were compiled from two independent experiments. Data in panel E were
generated by scoring duplicate transfections stained for either TIA-1 or G3BP and were compiled from two independent experiments. Transfection efficiency was
estimated by scoring the percentage of cells expressing mCherry in 10 fields of IG transfections. Error bars indicate standard errors of the means. ****,P 0.0001;
ns, difference not statistically significant.
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carrying a D215N mutation in vhs and to subsequently repair this
mutation (D215NRep). D215N virus exhibited a growth defi-
ciency in comparison to WT and D215NRep viruses on Vero cells
(Fig. 2A) and formed smaller plaques than either WT or
D215NRep on Vero cells (Fig. 2B and C). Importantly, no defects
in vhs packaging were observed with D215N vhs (Fig. 2D), mean-
ing that similar levels of WT or D215N vhs would be delivered to
cells upon entry. The vhs produced in cells infected with D215N
virus showed a slight increase in electrophoretic mobility com-
pared to the vhs produced in cells infected with WT or D215NRep
viruses (Fig. 2D). A similar observation was made with HSV-2
strain 333 carrying a D215N vhs (50). We previously reported that
cells infected with HSV-2 viruses carrying either a deletion of most
of the UL41 coding sequence (UL41) or a frameshift mutation in
UL41 at codon 343 formed spontaneous SGs late in infection (27).
Spontaneous SGs were observed in approximately 12% (39 of
319) of HeLa cells infected with D215N virus at an MOI of 4 at 5 h
postinfection (hpi). In keeping with our previous observations
(27), these SGs contained both ICP27 and Us3 (Fig. 2E).
To compare disruption of SG formation in infected cells, HeLa
cells were infected with WT, D215N, or D215NRep viruses at an
MOI of 4 or mock infected and then treated with either 500 mM
arsenite or 300 nM DMDA PatA at 4 hpi to induce SGs or left
untreated (data not shown). Infected cells were then fixed and
stained for the presence of TIA-1 and G3BP. Infectivity controls
on virus-infected samples confirmed that all cells were infected
under these conditions (data not shown). As shown in the top half
of Fig. 3A, cells infected with WT or D215NRep virus displayed a
disruption in their ability to form SGs in response to arsenite
treatment as indicated by a drastic decrease in the fraction of cells
with SGs (both less than 1% compared to greater than 98% in
mock-infected cells treated with arsenite). Cells infected with
D215N virus also showed a large decrease in the fraction of cells
with SGs (8%). This value was greater than that observed in un-
treated cells infected with D215N (less than 1%), indicating that,
at this time postinfection, spontaneous SG formation was not
contributing significantly to this value. A large decrease in the
fraction of cells with SGs was also observed when cells were in-
fected at a high MOI withUL41 virus (Fig. 3B), and this decrease
was comparable to that of D215N virus in this experiment. These
data suggest that an additional viral component or components
may be involved in disrupting arsenite-induced SG formation.
This possibility may have gone undetected in our previous char-
acterization of disruption of arsenite-induced SG formation by
UL41 virus, as only low-multiplicity infections were examined
(27). When disruption of arsenite-induced SG formation by
D215N and UL41 viruses was examined alongside WT virus at
low multiplicity, the fraction of infected cells with SGs was ap-
FIG 2 Characterization of D215N virus. (A) Vero cells were inoculated in duplicate at an MOI of 3 for 1 h, extracellular virus was inactivated by treatment with
low-pH citrate buffer, medium was replaced, and infected cells and medium were harvested together at the indicated time points. Harvested infected cells were
frozen and thawed twice and then centrifuged, and the clarified supernatants were titrated in duplicate on Vero cells. Each data point is the average of duplicate
values. The results from two independent experiments are shown. (B) Viral plaques were allowed to form on Vero cells for 3 days and then fixed and stained with
70% methanol containing 0.5% methylene blue. (C) Viral plaques were allowed to form on Vero cells for 24 h and then fixed and stained with rat polyclonal
antiserum specific for Us3 followed by staining with Alexa Fluor 488-conjugated donkey anti-rat IgG. For each virus, images of 40 plaques were captured on an
inverted epifluorescence microscope using a 4 objective. The area of plaques from these images was measured using Image-Pro Plus version 6.3 software. The
largest plaque area measured for the WT was set to 100, and other values were scored relative to it. Error bars indicate standard errors of the means. *, P 0.1;
ns, difference not statistically significant. (D) Virion preparations were separated on an SDS– 8% polyacrylamide gel and transferred to a polyvinylidene
difluoride (PVDF) membrane. The membrane was blocked overnight at 4°C in Tris-buffered saline with Tween 20 (TBST) containing 3% bovine serum albumin
(BSA), and the blocked membrane was probed for the presence of major capsid protein (ICP5) or vhs. Positions of molecular mass markers in kilodaltons are
indicated on the left. (E) HeLa cells were infected with D215N virus at an MOI of 4. At 5 hpi, infected cells were fixed and stained with goat polyclonal antiserum
specific for TIA-1, mouse monoclonal antibody specific for ICP27, and rat polyclonal antiserum specific for Us3 followed by staining with Alexa Fluor
488-conjugated donkey anti-goat IgG, Alexa Fluor 568-conjugated donkey anti-mouse IgG, and Alexa Fluor 647-conjugated chicken anti-rat IgG. Stained cells
were examined by confocal microscopy, and a representative merged image of an infected cell containing spontaneous SGs is shown. The scale bar is 10m. The
fluorescence intensity was measured across an approximately 9-m line drawn between adjacent SGs using Fluoview 1.7.3.0 software. The location of the
measurement line is shown on the merged image.
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proximately 85% for both D215N and UL41 viruses and was
significantly greater than the fraction of infected cells with SGs
observed for WT (P  0.0001) (Fig. 3C). Finally, in high-multi-
plicity infections at 1 hpi, no disruption of arsenite-induced SG
formation was detectable in either D215N or UL41 virus infec-
tions (Fig. 3D). As both WT and D215NRep viruses outperformed
D215N virus and D215N virus performed comparably to UL41
virus in our analyses of disruption of arsenite-induced SG forma-
tion, we conclude that endoribonuclease activity is required in
order for vhs to mediate this disruption. Disruption of arsenite-
induced SG formation by both D215N and UL41 virus de-
pended on the multiplicity of infection used as well as the length of
time that infections were allowed to proceed before arsenite treat-
ment, raising the possibility that another viral component may
contribute to this disruption.
In contrast to disruption of arsenite-induced SG formation,
disruption of DMDA PatA-induced SG formation was not de-
tected in cells infected at a high MOI with D215N virus (lower half
of Fig. 3A). The SGs remaining in D215N infections treated with
DMDA PatA contained both TIA-1 and G3BP, whereas those re-
maining in both WT and D215NRep virus infections were largely
devoid of TIA-1, an SG modification we had previously observed
in HSV-2-infected cells treated with PatA (26). Thus, in infected
cells, vhs can disrupt SG formation caused by eIF2 phosphory-
lation-dependent translational arrest and modify SG formation
caused by eIF2 phosphorylation-independent translational ar-
rest, and vhs-mediated disruption/modification of SG formation
in infected cells requires endoribonuclease activity.
Disassembly of preformed SGs can be mediated by vhs en-
doribonuclease activity. Conceivably, disruption of SG forma-
FIG 3 Analysis of SG formation in cells infected with vhs endoribonuclease-
deficient HSV-2. (A) HeLa cells were mock inoculated or inoculated for 1 h
with the indicated viruses at an MOI of 4. At 3.5 h after inoculation, infected
cells were treated with either 500 mM arsenite (ARS) or 300 nM DMDA PatA.
Thirty minutes later (4 hpi), infected cells were fixed and stained with goat
polyclonal antiserum specific for TIA-1 and mouse monoclonal antibody spe-
cific for G3BP followed by staining with Alexa Fluor 488-conjugated donkey
anti-goat IgG and Alexa Fluor 568-conjugated donkey anti-mouse IgG. Nuclei
were stained with Hoechst 33342. Stained cells were examined by confocal
microscopy, and with the exception of D215N virus infections treated with
arsenite, representative images are shown. In the case of high-multiplicity
D215N infections treated with arsenite, only approximately 8% of cells con-
tained stress granules (arrowhead), while the majority of cells did not contain
stress granules (arrow). Scale bars are 10 m. (B) HeLa cells were inoculated
for 1 h with the indicated viruses at an MOI of 4, treated with arsenite at 3.5 h
after inoculation for 30 min, and then fixed (4 hpi) and stained as described for
panel A. Samples were examined on an inverted epifluorescence microscope,
and the percentage of cells with SGs was scored in 20 fields per sample. (C)
HeLa cells were inoculated for 1 h with the indicated viruses at an MOI of 0.5,
treated with arsenite at 3.5 h after inoculation for 30 min, and then fixed (4 hpi)
and stained with goat polyclonal antiserum specific for TIA-1 and mouse
monoclonal antibody specific for ICP27 followed by staining with Alexa Fluor
488-conjugated donkey anti-goat IgG and Alexa Fluor 568-conjugated donkey
anti-mouse IgG. Nuclei were stained with Hoechst 33342. Samples were ex-
amined by confocal microscopy, and the percentage of infected cells (ICP27
positive) with SGs was scored in 30 fields per sample. (D) HeLa cells were
inoculated for 1 h with the indicated viruses at an MOI of 4, treated with
arsenite at 30 min after inoculation for 30 min, and then fixed (1 hpi) and
stained as described for panel A. Samples were examined on an inverted epi-
fluorescence microscope, and the percentage of cells with SGs was scored in 20
fields per sample. Error bars in panels B, C, and D indicate standard errors of
the means. ****, P  0.0001; ***, P  0.001; ns, difference not statistically
significant.
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tion could arise as a result of either prevention of SG assembly,
promotion of SG disassembly, or both of these activities. In our
preceding analyses of SG formation during viral infection, cells
were infected first and then SGs were induced, and so it was not
possible to distinguish between these two possibilities. To specif-
ically examine SG disassembly, we needed a method to generate
stable SGs so that the ability of HSV-2 to disassemble these pre-
formed SGs could be evaluated. SGs induced by PatA are known to
be much more stable than SGs induced by phosphorylation of
eIF2, remaining for as long as 12 h in cultured cells in the absence
of exogenous PatA (62). This stability likely results from incorpo-
ration of PatA into the resulting SGs via nonreversible binding to
eIF4A (5).
To determine if HSV-2 infection could promote the disassem-
bly of SGs, we pulse-treated HeLa cells with 300 nM DMDA PatA
to induce SGs and then examined the fate of the resulting SGs
following infection with HSV-2 or mock inoculum for 3 or 7 h
(Fig. 4A). In DMDA PatA-treated, mock-infected controls, gran-
ules positive for both TIA-1 and G3BP were still detectable 7 h
after removal of exogenous DMDA PatA (Fig. 4B) and showed no
detectable differences in size in comparison to the granules in
mock-infected controls at 3 h posttreatment (Fig. 4C). In contrast,
the granules remaining in DMDA PatA-treated cells infected with
WT HSV-2 for 3 h were smaller than those in their mock-infected
counterparts and were further decreased in size at the later time
point (Fig. 4B and C). Separate infectivity controls confirmed that
all cells were infected in this experiment (data not shown). The
decrease in SG size over time in infected cells indicates that HSV-2
is able to promote the disassembly of SGs. Furthermore, the gran-
ules remaining in DMDA PatA-treated cells infected for 7 h with
HSV-2 were positive for G3BP but were largely devoid of TIA-1
(bottom row of images in Fig. 4B), suggesting that during HSV-
2-mediated SG disassembly, TIA-1 departs in advance of G3BP.
To examine the requirement for HSV-2 vhs endoribonuclease
activity in SG disassembly, a similar experiment was conducted
comparing the sizes and compositions of DMDA PatA SGs follow-
ing infection for 7 h with WT, D215N, or D215NRep virus. In
these experiments, we used A549 cells that stably produce EGFP-
G3BP1 (A549 SGG cells) (51) to enable us to simultaneously de-
tect the SG markers G3BP and TIA-1 and the infectivity marker
ICP27. A549 SGG cells also formed stable SGs in response to treat-
ment with DMDA PatA (top two rows of images in Fig. 4D).
Granules remaining in DMDA PatA-treated cells infected with
WT or repair viruses were smaller than granules remaining in
mock-infected cells (Fig. 4E) and were positive for G3BP but
lacked TIA-1 (Fig. 4D). Granules remaining in DMDA PatA-
treated cells infected with D215N were positive for both G3BP and
TIA-1 and were similar in size to granules remaining in mock-
infected cells (Fig. 4E). Taken together, these data indicate that (i)
HSV-2 infection promotes the disassembly of preformed SGs, (ii)
HSV-2-mediated SG disassembly requires vhs endoribonuclease
activity, and (iii) during HSV-2-mediated SG disassembly, there is
an order to the departure of SG components, with TIA-1 depart-
ing in advance of G3BP.
vhs localizes to SGs. If vhs is able to mediate the disassembly of
preformed SGs, this predicts that vhs should localize to SGs. To
examine the subcellular localization of vhs, we constructed a myc-
tagged version of vhs carrying the D215N mutation (myc D215N
vhs). Removal of vhs endoribonuclease activity was necessary in
order to detect vhs and preserve SGs in transfected cells (data not
shown). HeLa cells transfected with myc D215N vhs expression
plasmids were treated with arsenite or DMDA PatA to induce SGs
or left untreated and then fixed and stained for TIA-1 to detect SGs
and the myc tag to detect vhs. Transfected cells in which the myc
tag signal was clearly enriched at SGs over the myc tag signal in the
surrounding cytoplasm were readily observed (Fig. 5A). This en-
richment was not observed in nontransfected cells (Fig. 5B). In
HeLa cells transfected with myc D215N vhs expression plasmid
but not treated with arsenite or DMDA PatA, approximately 13%
of transfected cells (25 of 195) formed SGs, presumably as a con-
sequence of overexpression of myc D215N vhs. vhs also localized
to these SGs (indicated by the asterisk in Fig. 5A). These data
indicate that vhs can localize to SGs induced by either arsenite or
DMDA PatA.
DISCUSSION
In this study, we demonstrate that endoribonuclease activity is
specifically required in order for vhs to disrupt SG formation re-
sulting from either eIF2 phosphorylation-dependent (arsenite)
or eIF2 phosphorylation-independent (DMDA PatA) mecha-
nisms of translational arrest in both transfected and infected cells.
Disruption of DMDA PatA-induced SG formation by vhs in WT
HSV-2 infected cells differed from that in vhs-transfected cells in
that SG formation was not thoroughly disrupted. Instead, gran-
ules remained that contained G3BP but were largely devoid of
TIA-1, as we had observed in our previous study (26). The in-
creased level of vhs in transfected versus infected cells is a plausible
explanation for the observed difference in disruption of DMDA
PatA-induced SGs by vhs in transfected versus infected cells. If
sufficient levels of vhs can thoroughly disrupt SG formation, then
the granules remaining in HSV-2-infected cells that are subse-
quently treated with PatA or DMDA PatA represent intermediates
in the assembly or, even more likely based on the results of our SG
disassembly analyses, the disassembly of SGs.
In our previous studies, we observed that the number of cells
containing SGs following transient overexpression of EGFP-
TIA-1, a condition that leads to SG formation (10), was noticeably
diminished when these cells were subsequently infected (26).
Based on this result, we hypothesized that HSV-2 infection could
promote the disassembly of preformed SGs. In support of this
hypothesis, we demonstrate in this work that HSV-2 infection can
promote SG disassembly in a manner that specifically requires vhs
endoribonuclease activity. SG disassembly was evidenced by both
a decrease in size of SGs over time as well as modification of SG
composition. If vhs can promote SG disassembly, it follows that
both vhs and XrnI should be able to localize to SGs. We demon-
strate here that HSV-2 vhs does indeed have the ability to localize
to SGs. While XrnI is often described as a marker of processing
bodies, another type of cytoplasmic RNA granule often found
associated with SGs (63), small amounts of XrnI have been found
to localize to SGs (64).
Two noteworthy features of SG disassembly were discovered
during the course of these studies. First, the requirement for vhs
endoribonuclease activity in SG disassembly implies that removal
of RNA from SGs promotes their disassembly and predicts that
intact RNA is crucial for maintaining the integrity of these cyto-
plasmic compartments. It will be interesting to test whether other
endoribonucleases promote SG disassembly and whether targeted
delivery of an endoribonuclease to SGs can be developed as a
means of disassembling SGs in vivo. Second, during SG disassem-
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bly there is an ordered departure of SG components, with TIA-1
departing before G3BP. Determination of whether this departure
order applies to disassembly of eIF2 phosphorylation-induced
SGs as well as whether a departure order can also be applied to
other SG components, including RNA, will be crucial in order to
establish that ordered departure of components is a general fea-
ture of SG disassembly. Very recently, the structure of arsenite-
induced SGs was examined by superresolution microscopy, re-
vealing that these SGs have a stable core structure, enriched in
G3BP, surrounded by a more dynamic shell (24). If SGs induced
by PatA/DMDA PatA share this structure, then the G3BP-con-
taining granules remaining after vhs-mediated disassembly may
represent the SG cores defined by this pioneering study. Isolated
SG cores were demonstrated to contain poly(A)	 RNA but were
found to be largely resistant to treatment with a cocktail of RNase
A and RNase T1 in vitro, suggesting that protein-protein interac-
FIG 4 Disassembly of DMDA PatA SGs by HSV-2 requires vhs endoribonuclease activity. (A) Timeline of experiment. Note that the hours postinfection (hpi)
shown refer to the total time in the presence of virus, including the 1-h inoculation period. (B) HeLa cells were pulse-treated with DMDA PatA to induce SGs and
then infected at an MOI of 6 or mock infected in the absence of exogenous DMDA PatA. Cells were fixed at the indicated times after infection and stained with
goat polyclonal antiserum specific for TIA-1 and mouse monoclonal antibody specific for G3BP followed by staining with Alexa Fluor 488-conjugated donkey
anti-mouse IgG and Alexa Fluor 488-conjugated donkey anti-goat IgG. Nuclei were stained with Hoechst 33342. Stained cells were examined by confocal
microscopy, and representative images are shown. Scale bars are 10m. (C) To compare the average sizes of the SGs following the conditions shown in panel B,
the area of 100 SGs from each condition was measured using Fluoview 1.7.3.0 software and then averaged. Error bars indicate standard errors of the means. ****,
P 0.0001; ns, difference not statistically significant. (D) A549 SGG cells were pulse-treated with DMDA PatA to induce SGs. DMDA PatA-treated samples were
then infected at an MOI of 4 with the indicated viruses or mock infected for 7 h in the absence of exogenous DMDA PatA. Untreated cells were mock infected for
7 h as well. Cells were fixed and stained with goat polyclonal antiserum specific for TIA-1 and mouse monoclonal antibody specific for ICP27 followed by staining
with Alexa Fluor 488-conjugated donkey anti-goat IgG and Alexa Fluor 647-conjugated donkey anti-mouse IgG. Stained cells were examined by confocal
microscopy, and representative images are shown. Scale bars are 10m. (E) To compare the average sizes of the SGs following the conditions shown in panel D,
the area of 100 SGs from each condition was measured using Fluoview 1.7.3.0 software and then averaged. Error bars indicate standard errors of the means. ****,
P 0.0001; ns, difference not statistically significant.
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FIG 5 vhs localizes to SGs. (A) HeLa cells were transfected with a myc-tagged D215N vhs expression construct. At 40 h posttransfection, cells were treated
with 0.5 mM arsenite (ARS) or 300 nM DMDA PatA for 30 min or left untreated and then fixed and stained with goat polyclonal antiserum specific for
TIA-1 and mouse monoclonal antibody specific for the myc tag followed by staining with Alexa Fluor 488-conjugated donkey anti-goat IgG and Alexa
Fluor 568-conjugated donkey anti-mouse IgG. Nuclei were stained with Hoechst 33342. Stained cells were examined by confocal microscopy. Arrows
indicate transfected cells, arrowheads indicate nontransfected cells, and an asterisk indicates an SG arising from overexpression of myc D215N vhs,
detectable in approximately 13% of untreated, transfected cells. Scale bars are 10 m. (B) The fluorescence intensity was measured across an approxi-
mately 6.5-m line drawn between adjacent SGs in transfected or nontransfected cells using Fluoview 1.7.3.0 software. The locations of the measurement
lines are shown on the merged image panels.
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tions could maintain the integrity of SG cores. Thus, it is plausible
that SG cores could remain after destruction of their RNA by vhs.
It will be of considerable interest to establish whether RNA is
present in the G3BP-containing granules remaining after vhs-me-
diated disassembly.
Our model for the two modes in which the endoribonu-
clease activity of vhs may be operating to disrupt SG formation
is presented in Fig. 6. The top mode, promotion of SG disas-
sembly, has been experimentally verified by our studies. The
bottom mode, prevention of SG assembly, can conceivably be
operating in addition to promotion of SG disassembly. This
model is in keeping with the crucial roles played by RNA in
initiating SG formation and, as we propose in this work, in
maintaining SG structure.
While the model presented in Fig. 6 focuses on the contribu-
tion of vhs to the disruption of SG formation, it is conceivable that
another viral component(s) also contributes to this disruption.
The data presented in Fig. 3 support the existence of such a com-
ponent. We have observed that disruption of SG formation con-
tinues to late times postinfection (26), when the endoribonu-
clease activity of vhs is predicted to be suppressed via the
interaction of vhs with VP16 and VP22 (65–68). Thus, another
viral component may be required later in infection to ensure
the continued disruption of SG formation. The identity of this
contributor remains to be determined; however, candidate vi-
ral proteins include those that localize to SGs (ICP27 and Us3)
(27) as well as those involved in counteracting eIF2 kinases and
the resulting phosphorylation of eIF2 (Us11, gB, and
ICP34.5) (69–72). In this regard, it is noteworthy that influenza
A virus deploys multiple proteins to disrupt SG formation
throughout viral replication (62, 73).
HSV strains carrying large deletions in the UL41 gene encoding
vhs have been reported to have two particular attributes: cells
infected with these viruses form spontaneous SGs late in infection
(27, 41, 74), and virus is unable to block activation of double-
stranded RNA-dependent eIF2 kinase (protein kinase R [PKR])
that arises as a result of infection (68, 75). In keeping with the first
attribute, we demonstrate here that specific removal of vhs en-
doribonuclease activity also results in spontaneous SG formation.
Roizman and colleagues have proposed that vhs, via its endoribo-
nuclease activity, can clear self-annealing RNAs that carry double-
stranded stretches capable of activating PKR (68). Furthermore,
Smiley and colleagues have recently demonstrated that PKR is
essential for the formation of spontaneous SGs in cells infected
with an HSV-1 vhs mutant (75), suggesting that these two attri-
butes are interrelated, with the first being a consequence of the
second. However, it is important to bear in mind that SGs are
being increasingly viewed as more than a mere consequence of a
cell’s stress response or a temporary storage depot for mRNPs.
Two independent research groups have shown that SGs can pro-
mote innate immune responses (76–79). This has led to the pro-
posal that SGs serve as platforms for recognizing and responding
to viral infections (80), which may explain why so many viruses
destroy or modify SGs during infection and necessitates a better
understanding of SG biology.
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been verified by work reported in this article. An additional possibility that remains to be experimentally verified is that vhs/XrnI activities promote the
destruction of mRNAs present in polysomes, free mRNPs, or submicroscopic coalesced mRNPs, which prevents the ensuing step in the SG assembly
pathway. For simplicity, microscopically visible SGs as well as submicroscopic SG nucleation sites are both represented as blue circles; visible SGs are often
irregular in shape and are variable in size.
Finnen et al.
7952 jvi.asm.org September 2016 Volume 90 Number 17Journal of Virology
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
FUNDING INFORMATION
This work, including the efforts of Bruce W. Banfield, was funded by
Natural Sciences and Engineering Research Council of Canada (NSERC)
(418719). This work, including the efforts of Bruce W. Banfield, was
funded by Canadian Institutes of Health Research (CIHR) (93804). This
work, including the efforts of Bruce W. Banfield, was funded by Canada
Foundation for Innovation (CFI) (16389).
REFERENCES
1. Anderson P, Kedersha N. 2008. Stress granules: the Tao of RNA triage.
Trends Biochem Sci 33:141–150. http://dx.doi.org/10.1016/j.tibs.2007.12
.003.
2. Wek RC, Jiang HY, Anthony TG. 2006. Coping with stress: eIF2 kinases
and translational control. Biochem Soc Trans 34:7–11. http://dx.doi.org
/10.1042/BST0340007.
3. Kedersha N, Ivanov P, Anderson P. 2013. Stress granules and cell sig-
naling: more than just a passing phase? Trends Biochem Sci 38:494 –506.
http://dx.doi.org/10.1016/j.tibs.2013.07.004.
4. Mazroui R, Sukarieh R, Bordeleau ME, Kaufman RJ, Northcote P,
Tanaka J, Gallouzi I, Pelletier J. 2006. Inhibition of ribosome recruit-
ment induces stress granule formation independently of eukaryotic initi-
ation factor 2alpha phosphorylation. Mol Biol Cell 17:4212– 4219. http:
//dx.doi.org/10.1091/mbc.E06-04-0318.
5. Dang Y, Kedersha N, Low WK, Romo D, Gorospe M, Kaufman R,
Anderson P, Liu JO. 2006. Eukaryotic initiation factor 2alpha-
independent pathway of stress granule induction by the natural product
pateamine A. J Biol Chem 281:32870 –32878. http://dx.doi.org/10.1074
/jbc.M606149200.
6. Kedersha N, Cho MR, Li W, Yacono PW, Chen S, Gilks N, Golan DE,
Anderson P. 2000. Dynamic shuttling of TIA-1 accompanies the recruit-
ment of mRNA to mammalian stress granules. J Cell Biol 151:1257–1268.
http://dx.doi.org/10.1083/jcb.151.6.1257.
7. Bounedjah O, Desforges B, Wu TD, Pioche-Durieu C, Marco S, Hamon
L, Curmi PA, Guerquin-Kern JL, Pietrement O, Pastre D. 2014. Free
mRNA in excess upon polysome dissociation is a scaffold for protein mul-
timerization to form stress granules. Nucleic Acids Res 42:8678 – 8691.
http://dx.doi.org/10.1093/nar/gku582.
8. Schwartz JC, Wang X, Podell ER, Cech TR. 2013. RNA seeds higher-
order assembly of FUS protein. Cell Rep 5:918 –925. http://dx.doi.org/10
.1016/j.celrep.2013.11.017.
9. Tourriere H, Chebli K, Zekri L, Courselaud B, Blanchard JM, Bertrand
E, Tazi J. 2003. The RasGAP-associated endoribonuclease G3BP assem-
bles stress granules. J Cell Biol 160:823– 831. http://dx.doi.org/10.1083/jcb
.200212128.
10. Gilks N, Kedersha N, Ayodele M, Shen L, Stoecklin G, Dember LM,
Anderson P. 2004. Stress granule assembly is mediated by prion-like ag-
gregation of TIA-1. Mol Biol Cell 15:5383–5398. http://dx.doi.org/10
.1091/mbc.E04-08-0715.
11. De Leeuw F, Zhang T, Wauquier C, Huez G, Kruys V, Gueydan C.
2007. The cold-inducible RNA-binding protein migrates from the nucleus
to cytoplasmic stress granules by a methylation-dependent mechanism
and acts as a translational repressor. Exp Cell Res 313:4130 – 4144. http:
//dx.doi.org/10.1016/j.yexcr.2007.09.017.
12. Dolzhanskaya N, Merz G, Aletta JM, Denman RB. 2006. Methylation
regulates the intracellular protein-protein and protein-RNA interactions
of FMRP. J Cell Sci 119:1933–1946. http://dx.doi.org/10.1242/jcs.02882.
13. Kwon S, Zhang Y, Matthias P. 2007. The deacetylase HDAC6 is a novel
critical component of stress granules involved in the stress response.
Genes Dev 21:3381–3394. http://dx.doi.org/10.1101/gad.461107.
14. Ohn T, Kedersha N, Hickman T, Tisdale S, Anderson P. 2008. A
functional RNAi screen links O-GlcNAc modification of ribosomal pro-
teins to stress granule and processing body assembly. Nat Cell Biol 10:
1224 –1231. http://dx.doi.org/10.1038/ncb1783.
15. Isabelle M, Gagne JP, Gallouzi IE, Poirier GG. 2012. Quantitative
proteomics and dynamic imaging reveal that G3BP-mediated stress gran-
ule assembly is poly(ADP-ribose)-dependent following exposure to
MNNG-induced DNA alkylation. J Cell Sci 125:4555– 4566. http://dx.doi
.org/10.1242/jcs.106963.
16. Leung A, Todorova T, Ando Y, Chang P. 2012. Poly(ADP-ribose)
regulates post-transcriptional gene regulation in the cytoplasm. RNA Biol
9:542–548. http://dx.doi.org/10.4161/rna.19899.
17. Leung AK, Vyas S, Rood JE, Bhutkar A, Sharp PA, Chang P. 2011.
Poly(ADP-ribose) regulates stress responses and microRNA activity in the
cytoplasm. Mol Cell 42:489 – 499. http://dx.doi.org/10.1016/j.molcel.2011
.04.015.
18. Kroschwald S, Maharana S, Mateju D, Malinovska L, Nuske E, Poser I,
Richter D, Alberti S. 2015. Promiscuous interactions and protein disag-
gregases determine the material state of stress-inducible RNP granules.
eLife 4:e06807. http://dx.doi.org/10.7554/eLife.06807.
19. Ivanov PA, Chudinova EM, Nadezhdina ES. 2003. Disruption of microtu-
bules inhibits cytoplasmic ribonucleoprotein stress granule formation. Exp
Cell Res 290:227–233. http://dx.doi.org/10.1016/S0014-4827(03)00290-8.
20. Ivanov PA, Chudinova EM, Nadezhdina ES. 2003. RNP stress-granule
formation is inhibited by microtubule disruption. Cell Biol Int 27:207–
208. http://dx.doi.org/10.1016/S1065-6995(02)00341-4.
21. Chernov KG, Barbet A, Hamon L, Ovchinnikov LP, Curmi PA, Pastre
D. 2009. Role of microtubules in stress granule assembly: microtubule
dynamical instability favors the formation of micrometric stress granules
in cells. J Biol Chem 284:36569 –36580. http://dx.doi.org/10.1074/jbc
.M109.042879.
22. Loschi M, Leishman CC, Berardone N, Boccaccio GL. 2009. Dynein and
kinesin regulate stress-granule and P-body dynamics. J Cell Sci 122:3973–
3982. http://dx.doi.org/10.1242/jcs.051383.
23. Rajgor D, Shanahan CM. 2014. RNA granules and cytoskeletal links.
Biochem Soc Trans 42:1206–1210. http://dx.doi.org/10.1042/BST20140067.
24. Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. 2016.
ATPase-modulated stress granules contain a diverse proteome and sub-
structure. Cell 164:487– 498. http://dx.doi.org/10.1016/j.cell.2015.12.038.
25. Wippich F, Bodenmiller B, Trajkovska MG, Wanka S, Aebersold R,
Pelkmans L. 2013. Dual specificity kinase DYRK3 couples stress granule
condensation/dissolution to mTORC1 signaling. Cell 152:791– 805. http:
//dx.doi.org/10.1016/j.cell.2013.01.033.
26. Finnen RL, Pangka KR, Banfield BW. 2012. Herpes simplex virus 2
infection impacts stress granule accumulation. J Virol 86:8119 – 8130.
http://dx.doi.org/10.1128/JVI.00313-12.
27. Finnen RL, Hay TJ, Dauber B, Smiley JR, Banfield BW. 2014. The
herpes simplex virus 2 virion-associated ribonuclease vhs interferes
with stress granule formation. J Virol 88:12727–12739. http://dx.doi
.org/10.1128/JVI.01554-14.
28. Everly DN, Jr, Feng P, Mian IS, Read GS. 2002. mRNA degradation by
the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and
biochemical evidence that Vhs is a nuclease. J Virol 76:8560 – 8571. http:
//dx.doi.org/10.1128/JVI.76.17.8560-8571.2002.
29. Zelus BD, Stewart RS, Ross J. 1996. The virion host shutoff protein of
herpes simplex virus type 1: messenger ribonucleolytic activity in vitro. J
Virol 70:2411–2419.
30. McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab
D, Perry LJ, Scott JE, Taylor P. 1988. The complete DNA sequence of the
long unique region in the genome of herpes simplex virus type 1. J Gen
Virol 69:1531–1574. http://dx.doi.org/10.1099/0022-1317-69-7-1531.
31. Morse LS, Pereira L, Roizman B, Schaffer PA. 1978. Anatomy of herpes
simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of poly-
peptides and functions specified by HSV-1HSV-2 recombinants. J Vi-
rol 26:389 – 410.
32. Read GS, Patterson M. 2007. Packaging of the virion host shutoff (Vhs)
protein of herpes simplex virus: two forms of the Vhs polypeptide are
associated with intranuclear B and C capsids, but only one is associated
with enveloped virions. J Virol 81:1148 –1161. http://dx.doi.org/10.1128
/JVI.01812-06.
33. Smibert CA, Johnson DC, Smiley JR. 1992. Identification and charac-
terization of the virion-induced host shutoff product of herpes simplex
virus gene UL41. J Gen Virol 73:467– 470. http://dx.doi.org/10.1099/0022
-1317-73-2-467.
34. Abernathy E, Glaunsinger B. 2015. Emerging roles for RNA degradation
in viral replication and antiviral defense. Virology 479–480:600 – 608.
http://dx.doi.org/10.1016/j.virol.2015.02.007.
35. Gaglia MM, Covarrubias S, WongW, Glaunsinger BA. 2012. A common
strategy for host RNA degradation by divergent viruses. J Virol 86:9527–
9530. http://dx.doi.org/10.1128/JVI.01230-12.
36. Spencer CA, Dahmus ME, Rice SA. 1997. Repression of host RNA
polymerase II transcription by herpes simplex virus type 1. J Virol 71:
2031–2040.
37. Hardy WR, Sandri-Goldin RM. 1994. Herpes simplex virus inhibits host
cell splicing, and regulatory protein ICP27 is required for this effect. J Virol
68:7790 –7799.
vhs Endoribonuclease Activity Drives SG Disruption
September 2016 Volume 90 Number 17 jvi.asm.org 7953Journal of Virology
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
38. Doepker RC, Hsu WL, Saffran HA, Smiley JR. 2004. Herpes simplex
virus virion host shutoff protein is stimulated by translation initiation
factors eIF4B and eIF4H. J Virol 78:4684 – 4699. http://dx.doi.org/10.1128
/JVI.78.9.4684-4699.2004.
39. Feng P, Everly DN, Jr, Read GS. 2005. mRNA decay during herpes
simplex virus (HSV) infections: protein-protein interactions involving the
HSV virion host shutoff protein and translation factors eIF4H and eIF4A.
J Virol 79:9651–9664. http://dx.doi.org/10.1128/JVI.79.15.9651-9664
.2005.
40. Page HG, Read GS. 2010. The virion host shutoff endonuclease (UL41) of
herpes simplex virus interacts with the cellular cap-binding complex
eIF4F. J Virol 84:6886 – 6890. http://dx.doi.org/10.1128/JVI.00166-10.
41. Dauber B, Pelletier J, Smiley JR. 2011. The herpes simplex virus 1 vhs
protein enhances translation of viral true late mRNAs and virus produc-
tion in a cell type-dependent manner. J Virol 85:5363–5373. http://dx.doi
.org/10.1128/JVI.00115-11.
42. Dauber B, Saffran HA, Smiley JR. 2014. The herpes simplex virus 1 virion
host shutoff protein enhances translation of viral late mRNAs by prevent-
ing mRNA overload. J Virol 88:9624 –9632. http://dx.doi.org/10.1128/JVI
.01350-14.
43. Saffran HA, Read GS, Smiley JR. 2010. Evidence for translational regu-
lation by the herpes simplex virus virion host shutoff protein. J Virol
84:6041– 6049. http://dx.doi.org/10.1128/JVI.01819-09.
44. Elgadi MM, Smiley JR. 1999. Picornavirus internal ribosome entry site
elements target RNA cleavage events induced by the herpes simplex virus
virion host shutoff protein. J Virol 73:9222–9231.
45. Kedersha N, Anderson P. 2009. Regulation of translation by stress gran-
ules and processing bodies. Prog Mol Biol Transl Sci 90:155–185. http://dx
.doi.org/10.1016/S1877-1173(09)90004-7.
46. Everly DN, Jr, Read GS. 1999. Site-directed mutagenesis of the virion
host shutoff gene (UL41) of herpes simplex virus (HSV): analysis of func-
tional differences between HSV type 1 (HSV-1) and HSV-2 alleles. J Virol
73:9117–9129.
47. Hosfield DJ, Mol CD, Shen B, Tainer JA. 1998. Structure of the DNA
repair and replication endonuclease and exonuclease FEN-1: coupling
DNA and PCNA binding to FEN-1 activity. Cell 95:135–146. http://dx.doi
.org/10.1016/S0092-8674(00)81789-4.
48. Tsutakawa SE, Classen S, Chapados BR, Arvai AS, Finger LD, Guenther
G, Tomlinson CG, Thompson P, Sarker AH, Shen B, Cooper PK,
Grasby JA, Tainer JA. 2011. Human flap endonuclease structures, DNA
double-base flipping, and a unified understanding of the FEN1 superfam-
ily. Cell 145:198 –211. http://dx.doi.org/10.1016/j.cell.2011.03.004.
49. Everett RD, Fenwick ML. 1990. Comparative DNA sequence analysis of
the host shutoff genes of different strains of herpes simplex virus: type 2
strain HG52 encodes a truncated UL41 product. J Gen Virol 71:1387–
1390. http://dx.doi.org/10.1099/0022-1317-71-6-1387.
50. Korom M, Wylie KM, Morrison LA. 2008. Selective ablation of virion
host shutoff protein RNase activity attenuates herpes simplex virus 2 in
mice. J Virol 82:3642–3653. http://dx.doi.org/10.1128/JVI.02409-07.
51. Khaperskyy DA, Hatchette TF, McCormick C. 2012. Influenza A virus
inhibits cytoplasmic stress granule formation. FASEB J 26:1629 –1639.
http://dx.doi.org/10.1096/fj.11-196915.
52. Le Sage V, Jung M, Alter JD, Wills EG, Johnston SM, Kawaguchi Y,
Baines JD, Banfield BW. 2013. The herpes simplex virus 2 UL21 protein
is essential for virus propagation. J Virol 87:5904 –5915. http://dx.doi.org
/10.1128/JVI.03489-12.
53. Tischer BK, Smith GA, Osterrieder N. 2010. En passant mutagenesis: a
two step markerless Red recombination system. Methods Mol Biol 634:
421– 430. http://dx.doi.org/10.1007/978-1-60761-652-8_30.
54. Romo D, Choi NS, Li S, Buchler I, Shi Z, Liu JO. 2004. Evidence for
separate binding and scaffolding domains in the immunosuppressive and
antitumor marine natural product, pateamine A: design, synthesis, and
activity studies leading to a potent simplified derivative. J Am Chem Soc
126:10582–10588. http://dx.doi.org/10.1021/ja040065s.
55. Finnen RL, Roy BB, Zhang H, Banfield BW. 2010. Analysis of filamen-
tous process induction and nuclear localization properties of the HSV-2
serine/threonine kinase Us3. Virology 397:23–33. http://dx.doi.org/10
.1016/j.virol.2009.11.012.
56. Lee GE, Church GA, Wilson DW. 2003. A subpopulation of tegument
protein vhs localizes to detergent-insoluble lipid rafts in herpes simplex
virus-infected cells. J Virol 77:2038 –2045. http://dx.doi.org/10.1128/JVI
.77.3.2038-2045.2003.
57. Lyman MG, Demmin GL, Banfield BW. 2003. The attenuated pseu-
dorabies virus strain Bartha fails to package the tegument proteins Us3
and VP22. J Virol 77:1403–1414. http://dx.doi.org/10.1128/JVI.77.2
.1403-1414.2003.
58. McEwen E, Kedersha N, Song B, Scheuner D, Gilks N, Han A, Chen JJ,
Anderson P, Kaufman RJ. 2005. Heme-regulated inhibitor kinase-
mediated phosphorylation of eukaryotic translation initiation factor 2 in-
hibits translation, induces stress granule formation, and mediates survival
upon arsenite exposure. J Biol Chem 280:16925–16933. http://dx.doi.org
/10.1074/jbc.M412882200.
59. Bordeleau ME, Cencic R, Lindqvist L, Oberer M, Northcote P, Wagner
G, Pelletier J. 2006. RNA-mediated sequestration of the RNA helicase
eIF4A by pateamine A inhibits translation initiation. Chem Biol 13:1287–
1295. http://dx.doi.org/10.1016/j.chembiol.2006.10.005.
60. Bordeleau ME, Matthews J, Wojnar JM, Lindqvist L, Novac O,
Jankowsky E, Sonenberg N, Northcote P, Teesdale-Spittle P, Pelletier J.
2005. Stimulation of mammalian translation initiation factor eIF4A activ-
ity by a small molecule inhibitor of eukaryotic translation. Proc Natl Acad
Sci U S A 102:10460 –10465. http://dx.doi.org/10.1073/pnas.0504249102.
61. Low WK, Dang Y, Schneider-Poetsch T, Shi Z, Choi NS, Merrick WC,
Romo D, Liu JO. 2005. Inhibition of eukaryotic translation initiation by
the marine natural product pateamine A. Mol Cell 20:709 –722. http://dx
.doi.org/10.1016/j.molcel.2005.10.008.
62. Khaperskyy DA, Emara MM, Johnston BP, Anderson P, Hatchette TF,
McCormick C. 2014. Influenza a virus host shutoff disables antiviral
stress-induced translation arrest. PLoS Pathog 10:e1004217. http://dx.doi
.org/10.1371/journal.ppat.1004217.
63. Stoecklin G, Kedersha N. 2013. Relationship of GW/P-bodies with stress
granules. Adv Exp Med Biol 768:197–211. http://dx.doi.org/10.1007/978
-1-4614-5107-5_12.
64. Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J,
Fritzler MJ, Scheuner D, Kaufman RJ, Golan DE, Anderson P. 2005.
Stress granules and processing bodies are dynamically linked sites of
mRNP remodeling. J Cell Biol 169:871– 884. http://dx.doi.org/10.1083
/jcb.200502088.
65. Knez J, Bilan PT, Capone JP. 2003. A single amino acid substitution in
herpes simplex virus type 1 VP16 inhibits binding to the virion host shut-
off protein and is incompatible with virus growth. J Virol 77:2892–2902.
http://dx.doi.org/10.1128/JVI.77.5.2892-2902.2003.
66. Lam Q, Smibert CA, Koop KE, Lavery C, Capone JP, Weinheimer SP,
Smiley JR. 1996. Herpes simplex virus VP16 rescues viral mRNA from
destruction by the virion host shutoff function. EMBO J 15:2575–2581.
67. Smibert CA, Popova B, Xiao P, Capone JP, Smiley JR. 1994. Herpes
simplex virus VP16 forms a complex with the virion host shutoff protein
vhs. J Virol 68:2339 –2346.
68. Sciortino MT, Taddeo B, Giuffre-Cuculletto M, Medici MA, Mastino A,
Roizman B. 2007. Replication-competent herpes simplex virus 1 isolates
selected from cells transfected with a bacterial artificial chromosome DNA
lacking only the UL49 gene vary with respect to the defect in the UL41 gene
encoding host shutoff RNase. J Virol 81:10924 –10932. http://dx.doi.org
/10.1128/JVI.01239-07.
69. Cassady KA, Gross M. 2002. The herpes simplex virus type 1 U(S)11
protein interacts with protein kinase R in infected cells and requires a
30-amino-acid sequence adjacent to a kinase substrate domain. J Virol
76:2029 –2035. http://dx.doi.org/10.1128/jvi.76.5.2029-2035.2002.
70. Cassady KA, Gross M, Roizman B. 1998. The herpes simplex virus US11
protein effectively compensates for the gamma1(34.5) gene if present be-
fore activation of protein kinase R by precluding its phosphorylation and
that of the alpha subunit of eukaryotic translation initiation factor 2. J
Virol 72:8620 – 8626.
71. Mulvey M, Arias C, Mohr I. 2007. Maintenance of endoplasmic
reticulum (ER) homeostasis in herpes simplex virus type 1-infected
cells through the association of a viral glycoprotein with PERK, a cel-
lular ER stress sensor. J Virol 81:3377–3390. http://dx.doi.org/10.1128
/JVI.02191-06.
72. He B, Gross M, Roizman B. 1997. The gamma(1)34.5 protein of herpes
simplex virus 1 complexes with protein phosphatase 1alpha to dephos-
phorylate the alpha subunit of the eukaryotic translation initiation factor
2 and preclude the shutoff of protein synthesis by double-stranded RNA-
activated protein kinase. Proc Natl Acad Sci U S A 94:843– 848. http://dx
.doi.org/10.1073/pnas.94.3.843.
73. Khaperskyy DA, McCormick C. 2015. Timing is everything: coordinated
control of host shutoff by influenza A virus NS1 and PA-X proteins. J Virol
89:6528 – 6531. http://dx.doi.org/10.1128/JVI.00386-15.
Finnen et al.
7954 jvi.asm.org September 2016 Volume 90 Number 17Journal of Virology
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
74. Esclatine A, Taddeo B, Roizman B. 2004. Herpes simplex virus 1 induces
cytoplasmic accumulation of TIA-1/TIAR and both synthesis and cyto-
plasmic accumulation of tristetraprolin, two cellular proteins that bind
and destabilize AU-rich RNAs. J Virol 78:8582– 8592. http://dx.doi.org/10
.1128/JVI.78.16.8582-8592.2004.
75. Dauber B, Poon D, Dos Santos T, Duguay BA, Mehta N, Saffran HA,
Smiley JR. 2016. The herpes simplex virus virion host shutoff protein
enhances translation of viral true late mRNAs independently of suppress-
ing protein kinase R and stress granule formation. J Virol 90:6049 – 6057.
http://dx.doi.org/10.1128/JVI.03180-15.
76. Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A,
Sambhara S, Kawaguchi A, Osari S, Nagata K, Matsumiya T, Namiki H,
Yoneyama M, Fujita T. 2012. Critical role of an antiviral stress granule
containing RIG-I and PKR in viral detection and innate immunity. PLoS
One 7:e43031. http://dx.doi.org/10.1371/journal.pone.0043031.
77. Oh SW, Onomoto K, Wakimoto M, Onoguchi K, Ishidate F, Fujiwara
T, Yoneyama M, Kato H, Fujita T. 2016. Leader-containing uncapped
viral transcript activates RIG-I in antiviral stress granules. PLoS Pathog
12:e1005444. http://dx.doi.org/10.1371/journal.ppat.1005444.
78. Reineke LC, Kedersha N, Langereis MA, van Kuppeveld FJ,
Lloyd RE. 2015. Stress granules regulate double-stranded RNA-
dependent protein kinase activation through a complex containing
G3BP1 and Caprin1. mBio 6:e02486. http://dx.doi.org/10.1128/mBio
.02486-14.
79. Reineke LC, Lloyd RE. 2015. The stress granule protein G3BP1 recruits
protein kinase R to promote multiple innate immune antiviral responses.
J Virol 89:2575–2589. http://dx.doi.org/10.1128/JVI.02791-14.
80. Onomoto K, Yoneyama M, Fung G, Kato H, Fujita T. 2014. Antiviral
innate immunity and stress granule responses. Trends Immunol 35:420 –
428. http://dx.doi.org/10.1016/j.it.2014.07.006.
vhs Endoribonuclease Activity Drives SG Disruption
September 2016 Volume 90 Number 17 jvi.asm.org 7955Journal of Virology
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
